Fujifilm Holdings Corp's research on Avigan as a potential treatment for COVID-19 may drag on until July, the company said on Sunday, a further setback in the Japanese firm's race to find a vaccine.
FILE PHOTO: Tablets of Avigan , a drug approved as an anti-influenza drug in Japan and developed by drug maker Toyama Chemical Co, a subsidiary of Fujifilm Holdings Co. are displayed during a photo opportunity at Fujifilm's headquarters in Tokyo October 22, 2014. REUTERS/Issei Kato/File Photo
“There is a possibility that clinical trials will continue in July,” a Fujifilm spokesman said, responding to a Nikkei report that any approval will be delayed until July or later, due to a lack of patients for trials. But researchers have only been able to get around 70% of the patients needed for the trials, and because it takes 28 days to get results, the process will continue until at least July, the Nikkei business daily said, citing an unnamed source.
Drugmakers around the world are scrambling to develop a vaccine for the new coronavirus, which has infected nearly 7 million people globally, while the disease it causes, COVID-19, has killed nearly 400,000.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Authors retract Lancet article that found risks in hydroxychloroquine against COVID-19An influential medical journal article that found hydroxychloroquine increased the risk of death in COVID-19 patients was retracted on Thursday, adding to controversy around a drug championed by U.S. President Donald Trump.
続きを読む »
UK halts trial of hydroxychloroquine as 'useless' for COVID-19 patientsBritish scientists halted a major drug trial on Friday after it found that the anti-malarial hydroxychloroquine, touted by U.S. President Donald Trump as a potential 'game changer' in the pandemic, was 'useless' at treating COVID-19 patients.
続きを読む »
States prod nursing homes to take more Covid-19 patientsPrograms designed to help elderly people with Covid-19 are creating a perverse financial incentive for nursing homes with bad track records to bring in sick patients, raising the risks of spreading infections and substandard care for seriously ill patients
続きを読む »
Germany helps sex workers idled by covid-19Though sex work is covered by grants of up to €9,000 for the self-employed in Germany, many prostitutes are ineligible
続きを読む »
Elon Musk calls for Amazon breakup after Covid-19 skeptic claims it censored his bookMusk has a record of making strange remarks on Twitter. His latest example was on May 1, when he tweeted that Tesla stock 'is too high.'
続きを読む »
Bombardier to cut 2,500 aviation jobs as COVID-19 hurts salesCanadian business jet maker Bombardier Inc said on Friday it would cut 2,500 jobs at its aviation unit and take a related charge of $40 million this year, as the COVID-19 pandemic hurts sales.
続きを読む »